• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依诺肝素预防 CXCL16/ADAM10 介导热疗顺铂肾毒性:凝血系统和转录因子 NF-κB 的作用。

Enoxaparin prevents CXCL16/ADAM10-mediated cisplatin renal toxicity: Role of the coagulation system and the transcriptional factor NF-κB.

机构信息

Pharmacology and Toxicology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.

Pharmacology and Toxicology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt; Pharmacology and Toxicology Department, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.

出版信息

Life Sci. 2021 Apr 1;270:119120. doi: 10.1016/j.lfs.2021.119120. Epub 2021 Feb 2.

DOI:10.1016/j.lfs.2021.119120
Abstract

BACKGROUND AND AIMS

C-X-C ligand 16 (CXCL16) is an exceptional chemokine that is expressed as transmembrane and soluble forms. Our aim is to shed lights on the role of CXCL16/ADAM10 (a disintegrin and metalloproteinase) in cisplatin (CP)-induced renal toxicity as well as possible protective effect of enoxaparin.

MAIN METHODS

Male albino mice were injected with CP (30 mg/kg, i.p.) in the presence or absence of enoxaparin (ENOX) (5 mg/kg, i.p.). Renal toxicity markers, serum level of cystatin-c, complete blood count (CBC), prothrombin time (Pt) and tissue expression of CXCL16, ADAM10, cluster of differentiation 3 (CD3), fibrinogen, tissue factor (TF), nuclear factor-κB (NF-κB) and tumour necrosis factor α (TNF-α) were measured. Besides, serum CXCL16 and histopathology were also analyzed.

KEY FINDINGS

CP increased renal toxicity markers, renal expression of CXCL16/ADAM10, fibrinogen, TF and CD3 tissue expression in a time-dependent manner, and elevated serum cystatin-c, CXCL16 and tissue TNF-α, NF-κB. Alternatively, ENOX restored the deteriorated parameters and reduced tissue level of NF-κB.

SIGNIFICANCE

This report, for the first time, showed that soluble CXCL16 resulting from ADAM10 cleavage may recruit T-cells to the renal glomeruli and tubules in CP toxicity. Furthermore, TF and fibrin, have similar expression and location pattern like CXCL16 and ADAM10 suggesting their possible interrelation. ENOX successfully restored the deteriorated parameters suggesting it may be an effective nephroprotective adjuvant therapy.

摘要

背景和目的

C-X-C 趋化因子配体 16(CXCL16)是一种特殊的趋化因子,可表达为跨膜和可溶性形式。我们的目的是阐明 CXCL16/ADAM10(解整合素和金属蛋白酶)在顺铂(CP)诱导的肾毒性中的作用以及依诺肝素的可能保护作用。

主要方法

雄性白化小鼠腹腔注射 CP(30mg/kg),并在存在或不存在依诺肝素(ENOX)(5mg/kg,腹腔注射)的情况下进行注射。测量肾毒性标志物、血清胱抑素 C 水平、全血细胞计数(CBC)、凝血酶原时间(Pt)以及 CXCL16、ADAM10、分化群 3(CD3)、纤维蛋白原、组织因子(TF)、核因子-κB(NF-κB)和肿瘤坏死因子-α(TNF-α)的组织表达。此外,还分析了血清 CXCL16 和组织病理学。

主要发现

CP 呈时间依赖性增加肾毒性标志物、肾脏 CXCL16/ADAM10、纤维蛋白原、TF 和 CD3 组织表达,并升高血清胱抑素 C、CXCL16 和组织 TNF-α、NF-κB。相反,ENOX 恢复了恶化的参数并降低了组织 NF-κB 水平。

意义

本报告首次表明,ADAM10 切割产生的可溶性 CXCL16 可能在 CP 毒性中招募 T 细胞到肾小球和肾小管。此外,TF 和纤维蛋白与 CXCL16 和 ADAM10 具有相似的表达和位置模式,表明它们可能存在相互关系。ENOX 成功恢复了恶化的参数,表明它可能是一种有效的肾保护辅助治疗方法。

相似文献

1
Enoxaparin prevents CXCL16/ADAM10-mediated cisplatin renal toxicity: Role of the coagulation system and the transcriptional factor NF-κB.依诺肝素预防 CXCL16/ADAM10 介导热疗顺铂肾毒性:凝血系统和转录因子 NF-κB 的作用。
Life Sci. 2021 Apr 1;270:119120. doi: 10.1016/j.lfs.2021.119120. Epub 2021 Feb 2.
2
The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.跨膜CXC趋化因子配体16由干扰素-γ和肿瘤坏死因子-α诱导产生,并通过去整合素样金属蛋白酶ADAM10的活性而脱落。
J Immunol. 2004 May 15;172(10):6362-72. doi: 10.4049/jimmunol.172.10.6362.
3
Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.正常及移植肾中CXCL16和ADAM10的特征分析
Kidney Int. 2008 Aug;74(3):328-38. doi: 10.1038/ki.2008.181. Epub 2008 May 14.
4
Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.可溶性 CXCL16 通过 AMAD10-NF-κB 调节反馈环促进 TNF-α 诱导的 DLBCL 细胞凋亡。
Cell Biol Int. 2019 Aug;43(8):863-874. doi: 10.1002/cbin.11154. Epub 2019 May 22.
5
A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.解整合素金属蛋白酶10介导的裂解和脱落调节CXC趋化因子配体16的细胞表面表达。
J Immunol. 2004 Mar 15;172(6):3678-85. doi: 10.4049/jimmunol.172.6.3678.
6
CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.趋化因子CXCL16在足细胞中表达,并作为氧化型低密度脂蛋白的清道夫受体发挥作用。
Am J Pathol. 2009 Jun;174(6):2061-72. doi: 10.2353/ajpath.2009.080960. Epub 2009 May 12.
7
Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes.整合素和金属蛋白酶10对跨膜趋化因子的调控性脱落促进黏附白细胞的脱离。
J Immunol. 2007 Jun 15;178(12):8064-72. doi: 10.4049/jimmunol.178.12.8064.
8
Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.肿瘤CXCL16表达是肾细胞癌患者生存时间更长的一种新型预后标志物。
Eur J Cancer. 2009 Feb;45(3):478-89. doi: 10.1016/j.ejca.2008.10.023. Epub 2008 Dec 11.
9
Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases.跨膜趋化因子CX3CL1和CXCL16经α-和γ-分泌酶的顺序加工
Biochem Biophys Res Commun. 2007 Jun 22;358(1):233-40. doi: 10.1016/j.bbrc.2007.04.100. Epub 2007 Apr 24.
10
CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.CXCL16 通过 ADAM10 依赖性 CXCL16/CXCR6 轴促进胃癌肿瘤发生,并激活 Akt 和 MAPK 信号通路。
Int J Biol Sci. 2021 Jul 5;17(11):2841-2852. doi: 10.7150/ijbs.57826. eCollection 2021.

引用本文的文献

1
Naringin mitigated doxorubicin-induced kidney injury by the reduction of oxidative stress and inflammation with a synergistic anticancer effect.柚皮苷通过减轻氧化应激和炎症反应以及协同抗癌作用减轻阿霉素诱导的肾损伤。
BMC Pharmacol Toxicol. 2025 Jun 23;26(1):121. doi: 10.1186/s40360-025-00947-7.
2
The role of CXCL16 in atherosclerosis: from mechanisms to therapy.CXCL16在动脉粥样硬化中的作用:从机制到治疗。
Front Immunol. 2025 May 26;16:1555438. doi: 10.3389/fimmu.2025.1555438. eCollection 2025.
3
The causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomization (MR).
免疫细胞与肝细胞癌之间的因果关系:孟德尔随机化研究(MR)
Ecancermedicalscience. 2024 Nov 8;18:1794. doi: 10.3332/ecancer.2024.1794. eCollection 2024.
4
Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase.使用磺达肝癸钠和阿替普酶评估顺铂诱导的急性肾衰竭的改善情况。
Pharmaceuticals (Basel). 2023 Jun 21;16(7):910. doi: 10.3390/ph16070910.
5
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.儿童癌症患者铂类药物所致耳毒性的全基因组分析:GO-CAT和英国MAGIC联盟的结果
Front Pharmacol. 2023 Jan 9;13:980309. doi: 10.3389/fphar.2022.980309. eCollection 2022.
6
Protective effect of alamandine on doxorubicin‑induced nephrotoxicity in rats.阿马林对多柔比星致大鼠肾毒性的保护作用。
BMC Pharmacol Toxicol. 2021 May 29;22(1):31. doi: 10.1186/s40360-021-00494-x.